Chronic Hepatitis C virus infection in Swiss primary care practices: Low case loads-high barriers to treatment?

被引:4
作者
Overbeck, Kathrin [2 ]
Bruggmann, Philip [3 ]
Helbling, Beat [1 ]
机构
[1] Stadtspital Waid, Dept Gastroenterol & Hepatol, CH-8037 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
[3] ARUD Assoc Risk Reduct Drugs, Zurich, Switzerland
关键词
Hepatitis C; primary care physician; disease workup; patient monitoring; barriers to treatment; THERAPY; MANAGEMENT; PREDICTORS; PHYSICIANS; PATIENT; RATES;
D O I
10.3109/13814788.2010.545122
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The primary care physician (PCP) diagnoses chronic Hepatitis C virus (HCV) infection in most patients. He serves as gatekeeper and plays a key role in counselling and treatment guidance. Objectives: To calculate the approximate HCV caseload per practice and characterize PCPs management of the disease; in particular, to determine antiviral treatment rates and reasons for PCPs for withholding treatment. The ultimate objective was to identify potentially modifiable barriers to treatment. Methods: A confidential self-administered questionnaire centred on the above-mentioned questions was distributed to 2371 Swiss primary care physicians. All respondents of the main questionnaire received an additional small questionnaire focussed on the initial disease workup. Descriptive statistics were used to describe questionnaire responses and PCP demographics. Results : The response rate was 53.1%. Of all participating PCPs (n = 1084), 86.2% reported having patients with chronic HCV, with an average number of 4 patients per practice; 18.6% (n = 142) of PCPs did not monitor their chronic HCV patients. Two-thirds (66.8%) of the sample chronic HCV patient population (n = 4626) never received antiviral therapy. The main reasons given by PCPs for withholding treatment were HCV-specialist advice, patient preference, normal liver enzymes and patient related factors like substance abuse or psychiatric co morbidity. Conclusions: Most PCPs follow patients with chronic hepatitis C, but practice caseloads are low, which may account for insecurity in managing this complex disease.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [1] Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
    Arora, Sanjeev
    Thornton, Karla
    Murata, Glen
    Deming, Paulina
    Kalishman, Summers
    Dion, Denise
    Parish, Brooke
    Burke, Thomas
    Pak, Wesley
    Dunkelberg, Jeffrey
    Kistin, Martin
    Brown, John
    Jenkusky, Steven
    Komaromy, Miriam
    Qualls, Clifford
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23) : 2199 - 2207
  • [2] Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices
    Nguyen, Vy H.
    Le, An K.
    Trinh, Huy N.
    Chung, Mimi
    Johnson, Tiffani
    Wong, Christopher
    Wong, Clifford
    Zhang, Jian
    Li, Jiayi
    Levitt, Brian S.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Henry, Linda
    Cheung, Ramsey
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 957 - +
  • [3] Treatment of chronic hepatitis C virus infection
    Malnick, SDH
    Beergabel, M
    Lurie, Y
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (10) : 1156 - 1164
  • [4] Identifying Barriers to the Treatment of Chronic Hepatitis C Infection
    Al-Khazraji, Ahmed
    Patel, Ishan
    Saleh, Mohammed
    Ashraf, Amar
    Lieber, Joseph
    Malik, Raza
    DIGESTIVE DISEASES, 2020, 38 (01) : 46 - 52
  • [5] DACLATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
    Temesgen, Z.
    Rizza, S. A.
    DRUGS OF TODAY, 2015, 51 (05) : 277 - 288
  • [6] ASUNAPREVIR PLUS DACLATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
    Zeuli, J. D.
    Adie, S. K.
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2015, 51 (11) : 629 - 643
  • [7] Quality of Care in Patients With Chronic Hepatitis C Virus Infection A Cohort Study
    Kanwal, Fasiha
    Schnitzler, Mark S.
    Bacon, Bruce R.
    Hoang, Tuyen
    Buchanan, Paula M.
    Asch, Steven M.
    ANNALS OF INTERNAL MEDICINE, 2010, 153 (04) : 231 - 239
  • [8] Examining hepatitis c virus testing practices in primary care clinics
    Almario, C. V.
    Vega, M.
    Trooskin, S. B.
    Navarro, V. J.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (02) : E163 - E169
  • [9] Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection
    Herbst, David Alan, Jr.
    Reddy, K. Rajender
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (04) : 527 - 536
  • [10] Increasing uptake of hepatitis C virus infection case-finding, testing, and treatment in primary care: evaluation of the HepCATT (Hepatitis C Assessment Through to Treatment) trial
    Horwood, Jeremy
    Clement, Clare
    Roberts, Kirsty
    Waldron, Cherry-Ann
    Irving, William L.
    Macleod, John
    Hickman, Mathew
    BRITISH JOURNAL OF GENERAL PRACTICE, 2020, 70 (697) : E581 - E588